GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunmax Biotechnology Co Ltd (ROCO:4728) » Definitions » Research & Development

Sunmax Biotechnology Co (ROCO:4728) Research & Development : NT$44 Mil (TTM As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Sunmax Biotechnology Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sunmax Biotechnology Co's Research & Development for the three months ended in Mar. 2025 was NT$14 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was NT$44 Mil.


Sunmax Biotechnology Co Research & Development Historical Data

The historical data trend for Sunmax Biotechnology Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunmax Biotechnology Co Research & Development Chart

Sunmax Biotechnology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.53 24.63 17.97 28.74 39.18

Sunmax Biotechnology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.84 9.17 6.50 14.67 13.68

Sunmax Biotechnology Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunmax Biotechnology Co  (ROCO:4728) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Sunmax Biotechnology Co Research & Development Related Terms

Thank you for viewing the detailed overview of Sunmax Biotechnology Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunmax Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
Huandong Road, New Urban District, 1st Floor, No. 10, Lane 31, Section 1, Tainan Science Industrial Park, Tainan, TWN
Sunmax Biotechnology Co Ltd is a biomedical company in Taiwan. It is engaged in the development, manufacturing, and commercialization of Sunmax medical devices and bio-surgical products. Additionally, it also researches, develops, manufactures and sales biomedical material grade collagen and related products. The company's products include medical products, biomedical materials, and porcine collagen skin care products.

Sunmax Biotechnology Co Headlines

No Headlines